Hhr Asset Management, LLC Editas Medicine, Inc. Transaction History

Hhr Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$39.71 - $90.58 $2.01 Million - $4.58 Million	-50,550 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$27.07 - $84.35 $473,995 - $1.48 Million	-17,510 Reduced 25.73%	50,550 $3.54 Million
Q3 2020 Nov 16, 2020	SELL	$28.06 - $37.16 $108,872 - $144,180	-3,880 Reduced 5.39%	68,060 $1.91 Million
Q2 2020 Aug 07, 2020	SELL	$18.5 - $34.34 $220,335 - $408,989	-11,910 Reduced 14.2%	71,940 $2.13 Million
Q4 2019 Feb 14, 2020	SELL	$19.49 - $32.63 $163,326 - $273,439	-8,380 Reduced 9.09%	83,850 $2.48 Million
Q2 2019 Aug 14, 2019	BUY	$20.48 - $27.76 $1.89 Million - $2.56 Million	92,230 New	92,230 $2.28 Million

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $164M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Hhr Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Hhr Asset Management, LLC with notifications on news.